898 abstracts found.



Results filter

Models for delivery of follow-up care – what does the evidence tell us thus far?

Year:

Session type:

Jon Emery1,

1University of Melbourne, Melbourne, Australia


Optimising care beyond breast cancer – perspectives from the front line

Year:

Session type:

Alastair M Thompson1, Maggie Wilcox2,
1University of Texas MD Anderson Cancer Center, Houston, USA,2Independent Cancer Patients' Voice, London, UK

Proton therapy: pushing the frontiers of radiotherapy

Year:

Session type:

Tony Lomax1,
1Centre for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland

Introduction: Inflammation and cancer

Year:

Session type:

Fran Balkwill1,
1Queen Mary, University of London, London, UK

Introduction: Cancer evolution

Year:

Session type:

Charles Swanton1,2,
1Cancer Research UK London Research Institute, London, UK,2niversity College London Cancer Institute, London, UK

Image guided radiation therapy

Year:

Session type:

Uwe Oelfke1,
1The Institute of Cancer Research UK and The Royal Marsden NHS Foundation Trust, London, UK

The targets for tumour immunotherapy mediated by the inflammatory properties of vesicular stomatitis virus (VSV)-based antigen presentation depend upon the tumour’s anatomical site

Year:

Session type:

Richard Vile1,
1Mayo Clinic, Rochester, USA

Making sense of intratumour heterogeneity: evidence of a ‘Big Bang’ tumour expansion

Year:

Session type:

Andrea Sottoriva1,
1The Institute of Cancer Research, London, UK

Introduction: Optimising care for those living with and beyond cancer – where does primary care fit in?

Year:

Session type:

Eila Watson1,
1Oxford Brookes University, UK, Oxford, UK

Co-targeting angiogenesis and immunosuppressive cell networks to improve anti-cancer therapy

Year:

Session type:

Michele De Palma1,
The Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland (1)

Page 1 of 901...25...Last »